Professors Chris Hawkey, Diane Stevenson and Jennifer Dumbleton, from the Nottingham Digestive Diseases Centre, and Professor Maarten Taal from the Centre for Kidney Research and Innovation, are part of a £3.9 million trial that aims to determine whether aspirin should be prescribed to people with kidney disease to help prevent heart attacks and strokes.
The research is being funded the National Institute for Health Research (NIHR) and the British Heart Foundation, and is thought to be the largest study of its kind in kidney patients. The team will look to recruit 23,000 people across the country in order to determine if a low dose of aspirin should be used to prevent a first heart attack and stroke in people with chronic kidney disease. The study, which will be known as ‘Aspirin To Target Arterial Events in Chronic Kidney Disease’ (ATTACK), will be led by Dr Hugh Gallagher from Epsom and St Helier.
The University of Nottingham will receive more than £1.7 million from the NIHR for this study.
The University of Nottingham
E Floor, West Block, Queen's Medical Centre
Nottingham, NG7 2UH
telephone: +44 (0) 115 82 31090
Connect with the University of Nottingham through social media and our blogs.
Campus maps | More contact information | Jobs